NCT06006845

Time to Initiated Antitumor Therapy for Tumor Patients With COVID19 Infection

When to Initiation Antitumor Therapy for Tumor Patients With COVID19 Infection

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: The Seventh Affiliated Hospital of Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The goal of this observational study is to study the safety of initiation of antitumor therapy early after nucleic acid test turn negativity in tumor patients infected with COVID-19. The main questions aims to answer are: * Whether initiation of antitumor therapy early after nucleic acid test turn negativity in tumor patients infected with COVID-19 increases adverse events related to antitumor therapy. * Whether initiation of antitumor therapy early after nucleic acid test turn negativity in tumor patients infected with COVID-19 increases risk of re-infection of COVID-19. * How initiation of antitumor therapy early after nucleic acid test turn negativity in tumor patients infected with COVID-19 affects QoL of tumor patients Participants will be asked to answer the question about: * the severity and duration of COVID-19 symptoms * the date of diagnosis of COVID-19 * the date of negative nucleic acid test * the QoL of life before infection with COVID-19, during infection of COVID-19, after nucleic acid test negativity and receiving antitumor therapy

Conditions

• Tumor
• COVID-19

Timeline

• Start date: 2022-12-01
• Primary completion: 2023-02-01
• Completion: 2024-08-31
• First posted: 2023-08-23
• Last updated: 2023-08-23

Locations

1 site across 1 country: China